A Study of DZD8586 Combination in CLL/SLL (TAI-SHAN10)

Clinical trial NCT07154264 · RECRUITING

Trial details

NCT number: NCT07154264
Sponsor: Dizal Pharmaceuticals
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Start date: 2025-09-22
Primary completion: 2029-12-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.